Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

Fig. 2

Mean before- and after-meal blood glucose levels following premixed insulin and IDegAsp use during the evaluation periods. Data are presented as means ± standard errors. Asterisks denote significant differences between treatments. IDegAsp insulin degludec/insulin aspart

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us